🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
587 medicines starting with “L”
MedicineActive substanceLicence holderStatus
Levothyroxine sodium Aristo 175 microgram tablets
PA1983/004/011
Levothyroxine Sodium Anhydrous EP Aristo Pharma GmbH Not marketed
Levothyroxine sodium Aristo 200 micrograms tablets
PA1983/004/004
Levothyroxine sodium Aristo Pharma GmbH Not marketed
Levothyroxine sodium Aristo 25 micrograms tablets
PA1983/004/001
Levothyroxine sodium Aristo Pharma GmbH Marketed
Levothyroxine sodium Aristo 50 micrograms tablets
PA1983/004/002
Levothyroxine sodium Aristo Pharma GmbH Marketed
Levothyroxine sodium Aristo 75 micrograms tablets
PA1983/004/005
Levothyroxine Sodium Anhydrous EP Aristo Pharma GmbH Not marketed
Levothyroxine sodium Aristo 88 microgram tablets
PA1983/004/008
Levothyroxine Sodium Anhydrous EP Aristo Pharma GmbH Not marketed
Levothyroxine sodium Rowex 100 microgram tablets
PA0711/354/004
Levothyroxine sodium Rowex Limited, Not marketed
Levothyroxine sodium Rowex 125 microgram tablets
PA0711/354/005
Levothyroxine sodium Rowex Limited, Not marketed
Levothyroxine sodium Rowex 150 microgram tablets
PA0711/354/006
Levothyroxine sodium Rowex Limited, Not marketed
Levothyroxine sodium Rowex 200 microgram tablets
PA0711/354/007
Levothyroxine sodium Rowex Limited, Not marketed
Levothyroxine sodium Rowex 25 microgram tablets
PA0711/354/001
Levothyroxine sodium Rowex Limited, Not marketed
Levothyroxine sodium Rowex 50 microgram tablets
PA0711/354/002
Levothyroxine sodium Rowex Limited, Not marketed
Levothyroxine sodium Rowex 75 microgram tablets
PA0711/354/003
Levothyroxine sodium Rowex Limited, Not marketed
Levothyroxine Teva 100 micrograms Tablets
PA0749/143/003
Levothyroxine sodium Teva Pharma B.V. Marketed
Levothyroxine Teva 25 micrograms Tablets
PA0749/143/001
Levothyroxine sodium Teva Pharma B.V. Marketed
Levothyroxine Teva 50 micrograms Tablets
PA0749/143/002
Levothyroxine sodium Teva Pharma B.V. Marketed
Lexapro 10 mg film-coated tablets
PA0805/002/002
Escitalopram H. Lundbeck A/S Not marketed
Lexapro 10 mg film-coated tablets
PPA0465/129/001
Escitalopram PCO Manufacturing Ltd.
Lexapro 10 mg film-coated tablets
PPA1463/241/002
Escitalopram IMED Healthcare Ltd.
Lexapro 15 mg film-coated tablets
PA0805/002/003
Escitalopram H. Lundbeck A/S Not marketed
Lexapro 15 mg film-coated tablets
PPA0465/129/004
Escitalopram PCO Manufacturing Ltd.
Lexapro 15 mg film-coated tablets
PPA1463/241/003
Escitalopram IMED Healthcare Ltd.
Lexapro 20 mg film-coated tablets
PA0805/002/004
Escitalopram H. Lundbeck A/S Not marketed
Lexapro 20 mg film-coated tablets
PPA0465/129/002
Escitalopram PCO Manufacturing Ltd.
Lexapro 20 mg film-coated tablets
PPA1463/241/004
Escitalopram IMED Healthcare Ltd.
Lexapro 5 mg film-coated tablets
PA0805/002/001
Escitalopram H. Lundbeck A/S Not marketed
Lexapro 5 mg film-coated tablets
PPA1463/241/001
Escitalopram IMED Healthcare Ltd.
Lexapro 5 mg film-coated tablets
PPA0465/129/005
Escitalopram PCO Manufacturing Ltd.
Lexotan 1.5mg Tablets
PA2239/008/001
Bromazepam CHEPLAPHARM Arzneimittel GmbH Marketed
Lexotan 3mg Tablets
PA2239/008/002
Bromazepam CHEPLAPHARM Arzneimittel GmbH Marketed
Leydex 100 mg Orodispersible Tablets
PA2241/001/004
Clozapine Leyden Delta BV
Leydex 12.5 mg Orodispersible Tablets
PA2241/001/001
Clozapine Leyden Delta BV
Leydex 200 mg Orodispersible Tablets
PA2241/001/005
Clozapine Leyden Delta BV
Leydex 25 mg Orodispersible tablets
PA2241/001/002
Clozapine Leyden Delta BV
Leydex 50 mg Orodispersible Tablets
PA2241/001/003
Clozapine Leyden Delta BV
LG-octaplas, Powder and solvent for solution for infusion
PA2219/002/002
Human plasma protein Octapharma (IP)
LG-octaplas, solution for infusion
PA2219/002/001
Human plasma protein Octapharma (IP) Marketed
Libmeldy 2-10 x 106 cells/mL dispersion for infusion
EU/1/20/1493/001
Autologous CD34+ cell enriched population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the Human Arylsulfatase a Gene Orchard Therapeutics (Netherlands) B.V.
Libmyris
EU/1/21/1590/001-006
Adalimumab Stada Arzneimittel AG
Libmyris 80 mg solution for injection in pre-filled syringe
EU/1/21/1590/007
Adalimumab Stada Arzneimittel AG
Librium 10mg Hard Capsule
PA23355/032/002
CHLORDIAZEPOXIDE HYDROCHLORIDE Viatris Healthcare Limited Marketed
Librium 5mg Hard Capsules
PA23355/032/001
CHLORDIAZEPOXIDE HYDROCHLORIDE Viatris Healthcare Limited Marketed
LIBTAYO 350 mg Concentrate for solution for infusion
EU/1/19/1376/001
CEMIPLIMAB Regeneron Ireland U.C.
Lidocaine 10 mg/ml (1% w/v) solution for injection in pre-filled syringe
PA1968/009/001
Lidocaine hydrochloride Laboratoire Aguettant Marketed
Lidocaine 20 mg/ml (2% w/v) solution for injection in pre-filled syringe
PA1968/009/002
Lidocaine hydrochloride Laboratoire Aguettant Not marketed
Lidocaine Hydrochloride 1% w/v Solution for Injection
PA2059/003/001
Lidocaine Hydrochloride Monohydrate Fresenius Kabi Deutschland GmbH Marketed
Lidocaine Hydrochloride 2% w/v Solution for Injection
PA2059/003/002
Lidocaine Hydrochloride Monohydrate Fresenius Kabi Deutschland GmbH Marketed
Lidocaine hydrochloride 20 mg/ml, solution for injection/infusion
PA1968/012/001
Lidocaine Hydrochloride Monohydrate Laboratoire Aguettant Not marketed
Lidocaine hydrochloride Noridem 10 mg/ml (1 % w/v) solution for injection
PA1122/027/001
Lidocaine Hydrochloride Monohydrate Noridem Enterprises Limited Not marketed
Lidocaine hydrochloride Noridem 20 mg/ml (2 % w/v) solution for injection
PA1122/027/002
Lidocaine Hydrochloride Monohydrate Noridem Enterprises Limited Not marketed
4 5 6 7 8 9 10

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.